From Name:
From Email:
To Name:
To Email:

Optional Message:

FDA designates MDMA as 'breakthrough therapy' for post-traumatic stress

from Forbes

Following years of lobbying and laboratory research on the medical uses of methylenedioxymethamphetamine, or MDMA, the U.S. Food and Drug Administration has decided to move forward with the drug. The Multidisciplinary Association for Psychedelic Studies (MAPS) recently announced that the FDA has granted Breakthrough Therapy Designation to MDMA for the treatment of post-traumatic stress disorder. more

Powered by MultiBriefs
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063